| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/22/2011 | CA2253875C Early detection of lysosomal storage disorders |
| 02/22/2011 | CA2251793C Multiplex amplification of short tandem repeat loci |
| 02/22/2011 | CA2239250C Novel bread improving composition |
| 02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
| 02/17/2011 | WO2011020118A1 Methods and compositions for treatment of tuberous sclerosis complex |
| 02/17/2011 | WO2011020090A2 Compositions and methods for treating cancer |
| 02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | WO2011020033A2 Engineered proteins including mutant fibronectin domains |
| 02/17/2011 | WO2011020014A1 Promoter-regulated differentiation-dependent self-deleting cassette |
| 02/17/2011 | WO2011020005A1 miRNA-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE |
| 02/17/2011 | WO2011019993A2 METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES |
| 02/17/2011 | WO2011019844A1 Transgenic animal for production of antibodies having minimal cdrs |
| 02/17/2011 | WO2011019815A2 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 02/17/2011 | WO2011019793A2 Individualized therapy of single gene disorders with genetically modified adult stem cells |
| 02/17/2011 | WO2011019763A2 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases |
| 02/17/2011 | WO2011019717A1 Positive and negative selectable markers for use in thermophilic organisms |
| 02/17/2011 | WO2011019704A2 Methods, primers, probes and kits useful for the detection of braf mutations |
| 02/17/2011 | WO2011019679A1 Ccr2 inhibitors for treating conditions of the eye |
| 02/17/2011 | WO2011019620A1 Antibodies with enhanced adcc function |
| 02/17/2011 | WO2011019391A1 Methods for enhancing the production and consumer traits of plants |
| 02/17/2011 | WO2011019385A1 Organisms homozygous for targeted modification |
| 02/17/2011 | WO2011019166A2 Method for producing viable tetraploid oysters |
| 02/17/2011 | WO2011019082A1 Method for measuring autophagy |
| 02/17/2011 | WO2011019081A1 Light-receiving channel rhodopsin having improved expression efficiency |
| 02/17/2011 | WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs |
| 02/17/2011 | WO2011019065A1 Tumor angiogenesis inhibitor |
| 02/17/2011 | WO2011019023A1 Agent for ameliorating blood-brain barrier disorders |
| 02/17/2011 | WO2011018898A1 Cdc45l as tumor marker and therapeutic target for cancer |
| 02/17/2011 | WO2011018766A1 A rational library |
| 02/17/2011 | WO2011018702A1 A method of producing virus-like particles |
| 02/17/2011 | WO2011018672A1 Methods and substances for stimulating muscle regeneration |
| 02/17/2011 | WO2011018662A1 Stress tolerant plants |
| 02/17/2011 | WO2011018506A1 miRNA COMPOUNDS FOR TREATMENT OF PROSTATE CARCINOMA |
| 02/17/2011 | WO2011018377A1 Fermentation process |
| 02/17/2011 | WO2011018376A1 Vector comprising mannose promoter and mannose promoter |
| 02/17/2011 | WO2011017910A1 Fusion protein mixture for inducing human pluripotent stem cell and preparation method thereof |
| 02/17/2011 | WO2011017808A1 Transformation of dicotyledonous plants by an isolated shoot apex meristem method |
| 02/17/2011 | WO2011017798A1 Aromatic prenyltransferase from cannabis |
| 02/17/2011 | WO2010147804A4 Method for dna double-strand break repair in vitro and applications thereof |
| 02/17/2011 | WO2010147654A3 Microfluid methods for forensic dna quantification |
| 02/17/2011 | WO2010142459A3 Method, compositions and devices for controlling a chemical reaction by pressure, using high-pressure optimized biocomponents |
| 02/17/2011 | WO2010136549A3 Modified aav capsid polypeptides |
| 02/17/2011 | WO2010135054A3 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine |
| 02/17/2011 | WO2010123527A3 Use of epidermal growth factor inhibitors in the treatment of viral infection |
| 02/17/2011 | WO2010122109A9 Method for the treatment of acute myeloid leukemia |
| 02/17/2011 | WO2010117620A3 Gene expression analysis in single cells |
| 02/17/2011 | WO2010114270A3 Method for selecting a high expression recombinant cell line |
| 02/17/2011 | WO2010104747A3 Antigen presenting cell targeted vaccines |
| 02/17/2011 | WO2010099489A3 Ovarian cancer methylome |
| 02/17/2011 | WO2010096603A3 Cancer-targeting peptides and uses thereof in cancer therapy |
| 02/17/2011 | WO2010046289A3 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases |
| 02/17/2011 | WO2010033639A9 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| 02/17/2011 | WO2007091064A8 End modification to prevent over-representation of fragments |
| 02/17/2011 | US20110041222 Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants |
| 02/17/2011 | US20110041221 Engineering enzymatically susceptible phytases |
| 02/17/2011 | US20110041219 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/17/2011 | US20110041218 Method for producing sclareol |
| 02/17/2011 | US20110041216 Nitrate reductases from red algae, compositions and methods of use thereof |
| 02/17/2011 | US20110041215 Lipid Metabolism Protein And Uses Thereof I (BZIP Transcription Factor) |
| 02/17/2011 | US20110041214 Genetic Markers For Orobanche Resistance in Sunflower |
| 02/17/2011 | US20110041213 Novel bacillus thuringiensis insecticidal proteins |
| 02/17/2011 | US20110041212 Storage-induced promoter |
| 02/17/2011 | US20110041211 Fiber-specific promoter elements |
| 02/17/2011 | US20110041210 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 02/17/2011 | US20110041209 Methods for increasing transformation frequency through the foliar application of copper amino acid chelate |
| 02/17/2011 | US20110041208 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/17/2011 | US20110041206 Tomato hybrid hns12846080 |
| 02/17/2011 | US20110041205 Tomato hybrid hnx12860544 |
| 02/17/2011 | US20110041204 Methods for enhancing the production and consumer traits of plants |
| 02/17/2011 | US20110041203 Soybean Cultivar 88220415 |
| 02/17/2011 | US20110041202 Soybean Cultivar S080173 |
| 02/17/2011 | US20110041201 Soybean Cultivar 8434328 |
| 02/17/2011 | US20110041200 Soybean Cultivar S090000 |
| 02/17/2011 | US20110041199 Soybean Cultivar 83181015 |
| 02/17/2011 | US20110041197 Promoter-Regulated Differentiation-Dependent Self-Deleting Cassette |
| 02/17/2011 | US20110041196 miRNA-Regulated Differentiation-Dependent Self-Deleting Cassette |
| 02/17/2011 | US20110041195 Organisms homozygous for targeted modification |
| 02/17/2011 | US20110041194 I-msoi homing endonuclease variants having novel substrate specificity and use thereof |
| 02/17/2011 | US20110041193 Non-human mammal model of epilepsy |
| 02/17/2011 | US20110041192 Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis |
| 02/17/2011 | US20110041191 Animal model, and products and methods useful for the production thereof |
| 02/17/2011 | US20110040077 Protein-Responsive Translational Regulatory System Using RNA-Protein Interacting Motif |
| 02/17/2011 | US20110040074 Production methods |
| 02/17/2011 | US20110039917 High Concentration Chitosan-Nucleic Acid Polyplex Compositions |
| 02/17/2011 | US20110039916 Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof |
| 02/17/2011 | US20110039915 IMMUNOSTIMULATORY siRNA MOLECULES |
| 02/17/2011 | US20110039914 Modified rnai polynucleotides and uses thereof |
| 02/17/2011 | US20110039912 Therapeutic Agent for Neuroblastoma Targeting ARID3b |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039909 Methods and materials for reducing gli2 expression |
| 02/17/2011 | US20110039859 Susceptibility to bone damage |
| 02/17/2011 | US20110039785 Polypeptide-nucleic acid conjugates and uses thereof |
| 02/17/2011 | US20110039780 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof |
| 02/17/2011 | US20110039775 Thyroid stimulating hormone fusion proteins |
| 02/17/2011 | US20110039773 BMP Mutants with Decreased Susceptibility to Noggin |
| 02/17/2011 | US20110039771 Small humanin-like peptides |
| 02/17/2011 | US20110039734 siRNA targeting connective tissue growth factor (CTGF) |
| 02/17/2011 | US20110039706 New mutated hydroxyphenylpyruvate dioxygenase, dna sequence and isolation of plants which are tolerant to hppd inhibitor herbicides |
| 02/17/2011 | US20110039340 Compositions and related methods for modulating transcriptional activation by incorporating gag motifs upstream of core promoter elements |
| 02/17/2011 | US20110039339 Process, Vectors and Engineered Cell Lines for Enhanced Large-Scale Transfection |